Characterization of nef gene of HIV type 1 in highly active antiretroviral therapy treated AIDS patients with discordance between viral load and CD4+ T cell counts

AIDS Research and Human Retroviruses

Volumn 18, Issue 13, 2002, Pages 983-987

  Saurya, Shreesh ^a   Lichtenstein, Zelman ^b   Karpas, Abraham ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b St Wolfgangs Platz   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; NEF PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE INSERTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; GENES, NEF; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

EID: 0036382895     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202760265650     Document Type: Article

References (14)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853-860.
2. Mocroft A, Vella S, Benfield TL, et al.: Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998;352:1725-1730.
3. Kaufmann D, Pantaleo G, Sudre P, and Telenti A: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet 1998;351:723-724.
4. + T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection. J Infect Dis 2000;181:946-953.
5. Lama J, Mangasarian A, and Trono D: Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr Biol 1999;9:622-631.
6. Ross TM, Oran AE, and Cullen BR: Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 1999;9:613-621.
7. Le Gall S, Prevost MC, Heard JM, and Schwartz O: Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity. Virology 1997;229:295-301.
8. Collins KL, Chen BK, Kalams SA, Walker BD, and Baltimore D: HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
9. Salvi R, Garbuglia AR, Di Caro A, Pulciani S, Montella F, and Benedetto A: Grossly defectivenef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol 1998;72:3646-3657.
10. Staden R, Beal KF, and Bonfield JK: The Staden package, 1998. Methods Mol Biol 2000;132:115-130.
11. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, and Higgins DG: The CLUSTAL_X Windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997;25:4876-4882.
12. Felsenstein J: Phylogenies from molecular sequences: Inference and reliability. Annu Rev Genet 1988;22:521-565.
13. Grzesiek S, Stahl SJ, Wingfield PT, and Bax A: The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef: Mapping of the Nef binding surface by NMR. Biochemistry 1996;35:10256-10261.
14. Greenberg M, DeTulleo L, Rapoport I, Skowronski J, and Kirchhausen T: A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Curr Biol 1998;8:1239-1242.